RCE 5.26% 60.0¢ recce pharmaceuticals ltd

Biotech Roundtable - virtual event in Germany

  1. 30 Posts.
    lightbulb Created with Sketch. 18
    great opportunity to hear James speak about EU/global strategy....

    DGWA and the German Australian Business Council are delighted to host the following virtual event. CEO Roundtable: Biotech Breakthroughs across Australia and Germany Tuesday, 1 March 2022 8:00am – 9:00 CET Online

    The global spotlight on the biotech industry over the pandemic has highlighted the importance and impact of the industry while accelerating innovation and investment across countries and companies. Join this discussion with leading CEOs from Australia and Germany as they navigate the biotech landscape from clinical trials to engaging stakeholders on their paths to commercial success.The speakers are:James Graham – CEO, Recce Pharmaceuticals, Mark Diamond – Managing Director & CEO, Antisense Therapeutics, Dr. Mohit Chhaya – Co-Founder & CEO, BellaSenoMarc Voigt – CEO & Executive Director, Immutep The session will be moderated byr. Julia Schueler - Chair, Founder & Owner Bio.AspekteDr. Lucia Santoso – Incoming Board Member, German Australian Business

    https://us02web.zoom.us/meeting/register/tZUucu2uqzgrGNxWPzMcnXaQ_kBF-WHacj58



 
watchlist Created with Sketch. Add RCE (ASX) to my watchlist
(20min delay)
Last
60.0¢
Change
0.030(5.26%)
Mkt cap ! $122.3M
Open High Low Value Volume
56.5¢ 62.0¢ 56.5¢ $158.1K 263.8K

Buyers (Bids)

No. Vol. Price($)
1 77741 60.0¢
 

Sellers (Offers)

Price($) Vol. No.
61.0¢ 30000 1
View Market Depth
Last trade - 16.10pm 28/06/2024 (20 minute delay) ?
RCE (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.